Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 15, Issue 9, Pages 15924-15950
Publisher
MDPI AG
Online
2014-09-09
DOI
10.3390/ijms150915924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is Insomnia a Perpetuating Factor for Late-Life Depression in the IMPACT Cohort?
- (2017) Wilfred R. Pigeon et al. SLEEP
- Nighttime Blood Pressure in Normotensive Subjects With Chronic Insomnia: Implications for Cardiovascular Risk
- (2017) Paola A. Lanfranchi et al. SLEEP
- Tasimelteon: First Global Approval
- (2014) Sohita Dhillon et al. DRUGS
- Ramelteon for the Treatment of Delirium in Elderly Patients: A Consecutive Case Series Study
- (2014) Akihiro Tsuda et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Disturbances in melatonin secretion and circadian sleep–wake regulation in Parkinson disease
- (2014) S.J. Bolitho et al. SLEEP MEDICINE
- Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
- (2014) D. Taylor et al. BMJ-British Medical Journal
- Does agomelatine have a place in the treatment of depression?
- (2014) G. Ambresin et al. BMJ-British Medical Journal
- Preventive Effects of Ramelteon on Delirium
- (2014) Kotaro Hatta et al. JAMA Psychiatry
- DSM-5 Sleep-Wake Disorders Classification: Overview for Use in Clinical Practice
- (2013) Charles F. Reynolds et al. AMERICAN JOURNAL OF PSYCHIATRY
- Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens
- (2013) Irina Vinogradova et al. BIOGERONTOLOGY
- The efficacy of agomelatine in previously-treated depressed patients
- (2013) Siegfried Kasper et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Use of Ramelteon for the Treatment of Secondary REM Sleep Behavior Disorder
- (2013) Takashi Nomura et al. INTERNAL MEDICINE
- Melatonin in Alzheimer’s Disease
- (2013) Li Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
- (2013) Daniel Cardinali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insomnia
- (2013) Daniel J. Buysse JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism
- (2013) Amit Naskar et al. JOURNAL OF PINEAL RESEARCH
- Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT Study in Norway
- (2013) Børge Sivertsen et al. JOURNAL OF SLEEP RESEARCH
- Poor sleep quality impairs cognitive performance in older adults
- (2013) Seiko Miyata et al. JOURNAL OF SLEEP RESEARCH
- Melatonin and its atheroprotective effects: A review
- (2013) Gaia Favero et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Sleep and Alzheimer disease pathology—a bidirectional relationship
- (2013) Yo-El S. Ju et al. Nature Reviews Neurology
- Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons
- (2013) Andrew S. P. Lim et al. SLEEP
- Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats
- (2013) Xiao-Jie Liu et al. SYNAPSE
- Sleep Quality and Preclinical Alzheimer Disease
- (2013) Yo-El S. Ju et al. JAMA Neurology
- Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression
- (2013) Carmela Calandra et al. Clinical Interventions in Aging
- Nocturnal Blood Pressure, Morning Blood Pressure Surge, and Cerebrovascular Events
- (2012) Yuichiro Yano et al. CURRENT HYPERTENSION REPORTS
- Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia
- (2012) Patrick Lemoine et al. EXPERT OPINION ON PHARMACOTHERAPY
- Sleep Disturbances in Parkinson's Disease With Emphasis on Rapid Eye Movement Sleep Behavior Disorder
- (2012) Anthony Barber et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder
- (2012) Edward R. Norris et al. JOURNAL OF AFFECTIVE DISORDERS
- Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases
- (2012) Sarah M. Rothman et al. NEUROMOLECULAR MEDICINE
- The Bidirectional Association Between Depression and Insomnia
- (2012) Børge Sivertsen et al. PSYCHOSOMATIC MEDICINE
- Repeated Melatonin Supplementation Improves Sleep in Hypertensive Patients Treated with Beta-Blockers: A Randomized Controlled Trial
- (2012) Frank A.J.L. Scheer et al. SLEEP
- Melatonin in autism spectrum disorders: a systematic review and meta-analysis
- (2011) DANIEL A ROSSIGNOL et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Cross-Sectional Associations Between Measures of Sleep and Markers of Glucose Metabolism Among Subjects With and Without Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study
- (2011) K. L. Knutson et al. DIABETES CARE
- A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
- (2011) Robert H. Howland DRUG SAFETY
- Agomelatine for the treatment of major depressive disorder
- (2011) Regina M Carney et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia
- (2011) Masako Kohsaka et al. Expert Review of Neurotherapeutics
- Decreased Slow Wave Sleep Increases Risk of Developing Hypertension in Elderly Men
- (2011) Maple M. Fung et al. HYPERTENSION
- When Parkinson’s disease patients go to sleep: specific sleep disturbances related to Parkinson’s disease
- (2011) Eva C. Schulte et al. JOURNAL OF NEUROLOGY
- Decreasing Sleep-Time Blood Pressure Determined by Ambulatory Monitoring Reduces Cardiovascular Risk
- (2011) Ramón C. Hermida et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Melatonin and the Metabolic Syndrome: Physiopathologic and Therapeutical Implications
- (2011) Daniel P. Cardinali et al. NEUROENDOCRINOLOGY
- Sleep Disorders in Parkinson Disease
- (2011) Alex Iranzo de Riquer et al. NEUROLOGIST
- Prolonged-Release Melatonin for Children With Neurodevelopmental Disorders
- (2011) Hélène De Leersnyder et al. PEDIATRIC NEUROLOGY
- Sleep Duration and Sleep Quality in Relation to 12-Year Cardiovascular Disease Incidence: The MORGEN Study
- (2011) Marieke P. Hoevenaar-Blom et al. SLEEP
- A review of ramelteon in the treatment of sleep disorders
- (2011) David Neubauer Neuropsychiatric Disease and Treatment
- Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection
- (2011) Venkatramanujam Srinivasan et al. Therapeutic Advances in Neurological Disorders
- Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
- (2010) Shao-wen Tian et al. ACTA PHARMACOLOGICA SINICA
- Genetic variants inMTNR1Baffecting insulin secretion
- (2010) Karsten Müssig et al. ANNALS OF MEDICINE
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
- (2010) Alan G Wade et al. BMC Medicine
- Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
- (2010) Alan G. Wade et al. CURRENT MEDICAL RESEARCH AND OPINION
- Diabetes and sleep: A complex cause-and-effect relationship
- (2010) Mark T.U. Barone et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance
- (2010) Susan L. McElroy et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
- (2010) Brent M. Egan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder
- (2010) Siegfried Kasper et al. JOURNAL OF CLINICAL PSYCHIATRY
- Urinary melatonin and risk of incident hypertension among young women
- (2010) John P Forman et al. JOURNAL OF HYPERTENSION
- Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril
- (2010) Fedor Simko et al. JOURNAL OF HYPERTENSION
- Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease
- (2010) Kathleen A. Maguire-Zeiss et al. JOURNAL OF NEURAL TRANSMISSION
- Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats
- (2010) You-Lin Tain et al. JOURNAL OF PINEAL RESEARCH
- Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β,tauand neuroinflammation
- (2010) Juliana Bender Hoppe et al. JOURNAL OF PINEAL RESEARCH
- Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome
- (2010) Marzena Koziróg et al. JOURNAL OF PINEAL RESEARCH
- Common Polymorphisms in MTNR1B, G6PC2 and GCK Are Associated with Increased Fasting Plasma Glucose and Impaired Beta-Cell Function in Chinese Subjects
- (2010) Claudia Ha Ting Tam et al. PLoS One
- Associations of nonrestorative sleep with insomnia, depression, and daytime function
- (2010) Khaled Sarsour et al. SLEEP MEDICINE
- New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
- (2010) Ruediger Hardeland Neuropsychiatric Disease and Treatment
- Ramelteon: a review of its therapeutic potential in sleep disorders
- (2009) Seithikurippu R. Pandi-Perumal et al. ADVANCES IN THERAPY
- Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease
- (2009) Philip R. Gehrman et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Insomnia and Sleep Duration as Mediators of the Relationship Between Depression and Hypertension Incidence
- (2009) J. E. Gangwisch et al. AMERICAN JOURNAL OF HYPERTENSION
- Agomelatine, a melatonin agonist with antidepressant properties
- (2009) Steven L Dubovsky et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats
- (2009) Fedor Simko et al. JOURNAL OF HYPERTENSION
- Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease
- (2009) James M. Olcese et al. JOURNAL OF PINEAL RESEARCH
- Agomelatine Treatment of Major Depressive Disorder
- (2008) Christian R Dolder et al. ANNALS OF PHARMACOTHERAPY
- Psychological distress and risk of pre-diabetes and Type2 diabetes in a prospective study of Swedish middle-aged men and women
- (2008) A.-K. Eriksson et al. DIABETIC MEDICINE
- A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population
- (2008) Markus Jansson-Fröjmark et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Melatonin and Bright-Light Treatment for RestâActivity Disruption in Institutionalized Patients with Alzheimer's Disease
- (2008) Glenna A. Dowling et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Association Between Depressive Symptoms and Sleep Disturbances in Community-Dwelling Older Men
- (2008) Misti L. Paudel et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials
- (2008) Shantha MW Rajaratnam et al. LANCET
- Variants in MTNR1B influence fasting glucose levels
- (2008) Inga Prokopenko et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started